UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000047780
Receipt number R000054468
Scientific Title Injection Site Local Reactions to Acellular Pertussis Vaccine in children
Date of disclosure of the study information 2022/06/01
Last modified on 2022/05/17 12:27:48

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Injection Site Local Reactions to Acellular Pertussis Vaccine in children

Acronym

DTaP study in Japan

Scientific Title

Injection Site Local Reactions to Acellular Pertussis Vaccine in children

Scientific Title:Acronym

DTaP study in Japan

Region

Japan


Condition

Condition

Pertussis, Diphtheria, Tetanus

Classification by specialty

Pediatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to assess the relationship between local reactions to diphtheria, tetanus toxoids and acellular pertussis (DTaP) vaccine and the injection site.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Local reactions by each injection site during 14 days after DTaP vaccination.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Cluster

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Vaccine

Interventions/Control_1

DTaP vaccination to the upper arm.

Interventions/Control_2

DTaP vaccination to the thigh.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

4 years-old <

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

4-6 year-old children,
11-13 year-old adolescents,
Any age of adult health care workers

Key exclusion criteria

1) Those who have been vaccinated with DTaP, DTaP-IPV, DT, Tdap within 6 months
2) Those who have received a total of 5 or more doses of DTaP, DTaP-IPV, DT, and Tdap vaccines
3) Contraindicated cases to DTaP vaccine
4) Pregnant women

Target sample size

450


Research contact person

Name of lead principal investigator

1st name Tomohiro
Middle name
Last name Katsuta

Organization

St. Marianna University School of Medicine

Division name

Department of pediatrics

Zip code

2168511

Address

2-16-1 Sugao, Miyamae-ku, Kawasaki-shi, Kanagawa, Japan

TEL

+81449778111

Email

katsuta-7-@marianna-u.ac.jp


Public contact

Name of contact person

1st name Tomohiro
Middle name
Last name Katsuta

Organization

St. Marianna University School of Medicine

Division name

Department of pediatrics

Zip code

2168511

Address

2-16-1 Sugao, Miyamae-ku, Kawasaki-shi, Kanagawa, Japan

TEL

+81449778111

Homepage URL


Email

katsuta-7-@marianna-u.ac.jp


Sponsor or person

Institute

St. Marianna University School of Medicine,
Department of pediatrics

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

St. Marianna University School of Medicine

Address

2-16-1 Sugao, Miyamae-ku, Kawasaki-shi, Kanagawa, Japan

Tel

+81449778111

Email

k-sienbu.mail@marianna-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 06 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2022 Year 05 Month 17 Day

Date of IRB


Anticipated trial start date

2022 Year 06 Month 01 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 05 Month 17 Day

Last modified on

2022 Year 05 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054468


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name